First National Bank & Trust Co. of Newtown Sells 248 Shares of Corteva, Inc. (NYSE:CTVA)

First National Bank & Trust Co. of Newtown cut its position in shares of Corteva, Inc. (NYSE:CTVA) by 2.0% in the fourth quarter, HoldingsChannel reports. The firm owned 12,044 shares of the company’s stock after selling 248 shares during the period. First National Bank & Trust Co. of Newtown’s holdings in Corteva were worth $577,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of CTVA. CVA Family Office LLC bought a new stake in Corteva during the 4th quarter valued at $25,000. BKM Wealth Management LLC purchased a new position in shares of Corteva in the 4th quarter valued at $27,000. NewSquare Capital LLC increased its holdings in shares of Corteva by 70.6% in the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock valued at $28,000 after acquiring an additional 226 shares during the period. Glass Jacobson Investment Advisors llc increased its holdings in shares of Corteva by 234.3% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock valued at $28,000 after acquiring an additional 389 shares during the period. Finally, Cornerstone Planning Group LLC purchased a new position in shares of Corteva in the 2nd quarter valued at $28,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance

CTVA traded up $0.49 on Friday, reaching $54.45. 658,509 shares of the stock were exchanged, compared to its average volume of 3,593,560. The company’s 50-day moving average price is $55.20 and its 200 day moving average price is $50.26. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $62.10. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.56 and a quick ratio of 0.90. The firm has a market capitalization of $38.05 billion, a PE ratio of 52.90, a PEG ratio of 1.40 and a beta of 0.77.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, February 1st. The company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.09. The company had revenue of $3.71 billion during the quarter, compared to analysts’ expectations of $3.54 billion. Corteva had a return on equity of 7.43% and a net margin of 4.27%. During the same quarter in the previous year, the firm posted $0.16 EPS. As a group, sell-side analysts forecast that Corteva, Inc. will post 2.84 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were issued a $0.16 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.64 annualized dividend and a dividend yield of 1.18%. Corteva’s dividend payout ratio (DPR) is presently 62.75%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price target on Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Mizuho cut their price target on Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. TheStreet upgraded Corteva from a “c+” rating to a “b-” rating in a report on Tuesday, February 27th. Oppenheimer boosted their target price on Corteva from $62.00 to $67.00 and gave the stock an “outperform” rating in a research note on Tuesday. Finally, BNP Paribas upgraded Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 target price on the stock in a research note on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $63.29.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.